OBI Pharma (4174)

TPEX

Currency in TWD

32.05

+0.55(+1.75%)

Delayed Data·27/04

Fair Value

Unlock Value

Day's Range

31.80

34.30

52 wk Range

22.85

55.90

4174 Income Statement

Assess the OBI Pharma income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 4174 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

18.77

4.71

41.55

62.68

58.58

Total Revenues Growth

aa.aa

-86.68%

-74.9%

+781.96%

+50.85%

-6.55%

Cost Of Revenues

aa.aa

44.36

44.86

115.05

138.95

136.1

Gross Profit

aa.aa

-25.59

-40.14

-73.5

-76.27

-77.53

Gross Profit Growth

aa.aa

-119.04%

-56.87%

-83.08%

-3.78%

-1.65%

Gross Profit Margin %

aa.aa

-136.32%

-852.13%

-176.89%

-121.69%

-132.36%

Other Operating Expenses, Total

aa.aa

1,690.42

2,082.62

2,016.29

2,295.25

2,091.26

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.63%	+23.2%	-3.18%	+13.84%	-8.89%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,449.6	1,772.86	1,697.02	1,968.48	1,729.29
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	240.83	309.76	319.28	326.78	361.96
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-1,716.01

-2,122.76

-2,089.79

-2,371.53

-2,168.79

Operating Income Growth

aa.aa

-17.06%

-23.7%

+1.55%

-13.48%

+8.55%

EBIT Margin %

aa.aa

-9,141.35%

-45,059.69%

-5,029.7%

-3,783.67%

-3,702.58%

Net Interest Expenses

aa.aa

2.66

45.94

85.02

29.42

16.66

Net Interest Expenses Growth

aa.aa

-93.22%

+1,627.11%

+85.06%

-65.4%

-43.37%

Interest Expense, Total

aa.aa

-3.8

-3.99

-7.94

-10.65

-13.13

Interest And Investment Income

aa.aa

6.46

49.93

92.96

40.07

29.79

Other Non Operating Expenses, Total

aa.aa

-33.85

160.74

-141.75

-198.08

-149.14

EBT, Excl. Unusual Items

aa.aa

-1,747.2

-1,916.08

-2,146.52

-2,540.19

-2,301.27

Gain (Loss) On Sale Of Assets

aa.aa

-15.08

0.01

-0.39

43.72

44.88

Other Unusual Items, Total

aa.aa

-7.96

-3

EBT, Incl. Unusual Items

aa.aa

-1,742.25

-1,917.09

-1,275.55

-2,496.21

-2,259.48

EBT, Incl. Unusual Items Growth

aa.aa

-16.64%

-10.04%

+33.46%

-95.7%

+9.48%

EBT, Incl. Unusual Items Margin

aa.aa

-9,281.13%

-40,693.95%

-3,070%

-3,982.59%

-3,857.41%

Income Tax Expense

aa.aa

-24.36

-17.77

-9.59

-3.56

-2.73

Net Income to Company

aa.aa

-1,717.89

-1,899.32

-1,265.96

-2,492.65

-2,256.75

Minority Interest

aa.aa

187.2

285.41

219.49

182.62

203.93

Net Income

aa.aa

-1,530.69

-1,613.92

-1,046.48

-2,310.03

-2,052.82

Net Income Growth

aa.aa

-11.09%

-5.44%

+35.16%

-120.74%

+11.13%

Net Income Margin %

aa.aa

-8,154.1%

-34,258.46%

-2,518.65%

-3,685.55%

-3,504.61%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-1,530.69

-1,613.92

-1,046.48

-2,310.03

-2,052.82

Basic EPS - Continuing Operations

aa.aa

-15.39

-14.53

-9.14

-19.78

-15.61

Basic EPS - Continuing Operations Growth

aa.aa

-10.89%

+5.57%

+37.12%

-116.43%

+21.05%

Diluted EPS - Continuing Operations

aa.aa

-15.39

-14.53

-9.14

-19.78

-15.61

Diluted EPS - Continuing Operations Growth

aa.aa

-10.89%

+5.57%

+37.12%

-116.43%

+21.05%

Basic Weighted Average Shares Outstanding

aa.aa

99.47

111.06

114.53

116.81

131.48

Diluted Weighted Average Shares Outstanding

aa.aa

99.47

111.06

114.53

116.81

131.48

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-1,558.78

-1,934.75

-1,910.59

-2,210.11

-2,003.26

EBITDA Growth

aa.aa

-20.04%

-24.12%

+1.25%

-15.68%

+9.36%

EBITDA Margin %

aa.aa

-8,303.72%

-41,068.78%

-4,598.4%

-3,526.13%

-3,419.99%

EBIT

aa.aa

-1,716.01

-2,122.76

-2,089.79

-2,371.53

-2,168.79

* In Millions of TWD (except for per share items)

FAQ

What was OBI Pharma’s revenue at year end?

At the end of the last reported fiscal year, OBI Pharma (4174) recorded total revenue of 58.58 million TWD.

How much revenue did OBI Pharma report in the most recent quarter?

In its most recent quarterly earnings report, OBI Pharma posted revenue of 20.84 million TWD.

What was OBI Pharma’s net income for the year?

For the full year, OBI Pharma reported net income of -2,052.82 million TWD.

How much net income did OBI Pharma post in the last quarter?

In the most recent quarter, OBI Pharma (4174) posted net income of -419.46 million TWD.

What was OBI Pharma’s gross profit for the year?

Gross profit for the year was reported at -77.53 million TWD.

How much gross profit did OBI Pharma generate last quarter?

OBI Pharma recorded gross profit of -15.86 million TWD in its latest quarterly report.

What was OBI Pharma’s annual operating income?

For the full year, OBI Pharma (4174) reported operating income of -2,168.79 million TWD.

What was OBI Pharma’s operating income last quarter?

Quarterly operating income was -477.17 million TWD.

What was OBI Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -439.28 million TWD.

What was the quarter-over-quarter change in EBITDA for OBI Pharma?

EBITDA changed by 3.79% million TWD compared to the last quarter.

What is OBI Pharma’s most recent gross profit margin?

The latest reported gross profit margin for OBI Pharma (4174) is -76.10% million TWD.

What is OBI Pharma’s most recent net income margin?

Net income margin based on recent financials is -2,013.06% million TWD.

What is OBI Pharma’s most recent EBIT margin?

OBI Pharma reported an EBIT margin of -2,289.99% million TWD based on current figures.

How did OBI Pharma’s revenue change compared to the previous quarter?

Revenue changed by 98.03% million TWD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for OBI Pharma?

In the latest quarter, gross profit changed by 28.77% million TWD from the previous quarter.

S&P/TSX

33,584.34

-233.85

-0.69%

S&P/TSX 60

1,958.99

-9.72

-0.49%

US 30

49,231.60

+95.4

+0.19%

US 500

7,154.00

+15.2

+0.21%

S&P 500 VIX

17.83

-0.19

-1.05%

DAX

24,018.26

-65.27

-0.27%

Dollar Index

98.53

+0.054

+0.05%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	31.37	+0.48%	23.32M
Enbridge	72.61	+1.45%	7.60M
TC Energy	86.19	+2.02%	6.89M
Bank of Nova Scotia	104.90	+0.62%	5.63M
RBC	243.14	+0.98%	5.36M
Toronto Dominion Bank	144.14	0.00%	5.32M
Bank of Montreal	207.20	-0.28%	4.69M

Name	Last	Chg. %	Vol.
Vector Science Therapeutics	0.37	+640.00%	171.60K
PeakBirch Logic	0.030	+500.00%	1.32K
1933 Industries	0.01	+200.00%	30.00K
Irwin Naturals	0.30	+150.00%	3.24K
Dixie Gold	0.0350	+133.33%	1.69M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Montfort Capital	0.0050	-66.67%	472.92K
Resource Centrix Holdings	1.50	-60.00%	600.00
Dixie Gold	0.035	-56.25%	2.69K
Patriot Gold	0.07	-51.85%	1.00K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	493.22	-14.48%	956.60K
TELUS	16.85	+1.63%	9.17M
Canadian Natural	63.44	+3.27%	5.85M
ARC Resources	31.37	+0.48%	23.32M
Canadian Imperial Bank	149.88	-0.49%	1.62M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa	5.17	+66.53%	8.61
Aaaaaaaa	6.01	+55.33%	9.34
Aaaaa Aaaaaaa Aaa	100.64	+54.36%	155.35
Aaaaaaa	2,434.99	+49.94%	3,651.02
Aaaaaaaaa Aaaaaa	10.68	+43.78%	15.36
A Aaaaaaaaaaa	113.28	+39.81%	158.38
A Aaaa	22.98	+39.51%	32.06

Name	Last	Upside	Fair Value
Aaaa	5.17	+66.53%	8.61
Aaaaaaaa	6.01	+55.33%	9.34
Aaaaa Aaaaaaa Aaa	100.64	+54.36%	155.35
Aaaaaaa	2,434.99	+49.94%	3,651.02
Aaaaaaaaa Aaaaaa	10.68	+43.78%	15.36
A Aaaaaaaaaaa	113.28	+39.81%	158.38
A Aaaa	22.98	+39.51%	32.06

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

OBI Pharma (4174)

4174 Income Statement

FAQ

What was OBI Pharma’s revenue at year end?

How much revenue did OBI Pharma report in the most recent quarter?

What was OBI Pharma’s net income for the year?

How much net income did OBI Pharma post in the last quarter?

What was OBI Pharma’s gross profit for the year?

How much gross profit did OBI Pharma generate last quarter?

What was OBI Pharma’s annual operating income?

What was OBI Pharma’s operating income last quarter?

What was OBI Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for OBI Pharma?

What is OBI Pharma’s most recent gross profit margin?

What is OBI Pharma’s most recent net income margin?

What is OBI Pharma’s most recent EBIT margin?

How did OBI Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for OBI Pharma?

Trending Stocks